Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Power3 Medical Announces Better Than Expected Results For Early Stage Diagnosis Capability Of The NuroPro(R) PD Test For Parkinson's Disease
Power3 Medical Products, Inc. (OTCBB: PWRM), announced that results for the early stage diagnosis from clinical validation trials of the NuroPro® PD test for Parkinson"s disease are better than expected. The NuroPro PD test was developed to help clinicians distinguish patients with Parkinson"s disease from "normal" individuals and patients with other neurological disorders. The NuroPro PD test, developed by Power3, utilizes a panel of blood serum protein biomarkers evaluated by biostatistical analysis to predict the probability that a patient has Parkinson"s disease. The test is intended to solve a critical challenge facing physicians, clinicians, and patients for a quick, early stage and accurate diagnosis of the debilitating disease known as Parkinson"s.
generic viagra online
Health Professions Council Take Advice Of Psychology Experts
The British Psychological Society has today welcomed the announcement by the Health Professions Council (HPC) to set high entry level qualifications for psychologists to be admitted to the forthcoming statutory register of Practitioner Psychologists.
News of the day
Gene Regulates Immune Cells' Ability To Harm The Body
A recently identified gene allows immune cells to start the self-destructive processes thought to underlie autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis, researchers at Washington University School of Medicine in St. Louis have found.
Mental Health

Award-winning Accu-Chek Website Launches In The UK

Accu-Chek has launched an award-wining website for people with diabetes. Patients can now be informed about Accu-Chek"s news and products via an award-winning site packed with engaging interactive tools, such as videos and an online ordering facility, in a layout which allows the user to surf effortlessly through the content. The Webby Award which is a highly recognised international prize to honour excellence over the internet placed the Accu-Chek site within the top 15% of over 10,000 website submissions. "We are delighted that the Accu-Chek site has been recognised in this way. The new interactive marketing approach adopted by the Accu-Chek team has really advanced the brand and has provided a richer and more fulfilling interactive experience for the customer," said Brett Lewis, Director of Diabetes Care at Roche Diagnostics Limited. The new look of the website was tested with customers in the UK, USA and Germany. Its interactive guide to the Accu-Chek product family helps patients to find the blood glucose system that best fits their lifestyle. The website redesign enhances customers" experience and was developed following patient requests to better meet the needs of users. "We have found that customers are looking for more product information from our website as opposed to general diabetes health advice. The Accu-Chek website therefore guides patients through the portfolio and directs them to state-of-the-art medical websites, where they can find reliable and up-to date information on their condition," continued Brett Lewis. Throughout the UK more than 21,000 patients and healthcare professionals visit the site every month. To experience the site for yourself, please visit: http://www.accu-chek.co.uk. Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009